Agenus Inc. Share Price
NASDAQ: AGEN | Micro CapAgenus Inc. Stock Performance
Agenus Inc. Share Price Today
As of 31 October 2026, Agenus Inc.'s share price is $6.83. The stock opened at $6.87, compared to its previous close of $7.10. During today's trading session, Agenus Inc.'s share price traded between $6.70 and $7.07, with an average price of $6.88. Over the past 52 weeks, the stock has recorded a high of $10.22 and a low of $2.73. In terms of performance, Agenus Inc.'s share price has risen by 75.03% over the last six months and is up 72.60% on a year-on-year basis.
Agenus Inc. Share Price Chart
Agenus Inc. Quarterly Profit & Loss
All figures in USD
Agenus Inc. Annual Profit & Loss
All figures in USD
About Agenus Inc.
Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.
Agenus Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $9.95 | $6.83 | -31.61% |
Sep 2026 | $7.64 | $9.98 | +27.87% |
Aug 2026 | $7.62 | $7.80 | +4.07% |
Jul 2026 | $3.10 | $7.50 | +146.31% |
Jun 2026 | $3.51 | $3.04 | -12.75% |
May 2026 | $3.81 | $3.49 | -10.63% |
Apr 2026 | $3.43 | $3.90 | +16.57% |
Mar 2026 | $3.27 | $3.35 | +0.60% |
Feb 2026 | $2.92 | $3.33 | +17.67% |
Jan 2026 | $3.15 | $2.83 | -9.73% |
Dec 2025 | $4.47 | $3.13 | -30.95% |
Nov 2025 | $3.96 | $4.54 | +14.65% |